Senores Pharma makes strong debut; lists over 53% premium on NSE
Senores Pharmaceuticals had a successful IPO listing, with its shares trading at a premium of 53.4% and 51.8% on the National Stock Exchange and BSE, respectively. The company's shares were also trading at a premium of Rs 675 in the grey market, indicating a potential 72.6% gain. The IPO was subscribed 97.86 times, with the company raising Rs 582.11 crore.